It’s been almost a year since the World Health Organization declared the coronavirus outbreak a pandemic.
And the virus is persisting: A downward trend in the U.S. caseload has stalled, and concern about the impact of variants is growing. Yet inoculations are on the rise, and the F.D.A. has approved Johnson & Johnson’s single-dose vaccine, the third to be a ... Show More
Yesterday
Martin McDonagh Has a Vision for Hope. It's Not for the Faint of Heart.
The writer-director, known for his dark and bleak work, believes in film’s power to change our lives.Thoughts? Email us at theinterview@nytimes.comWatch our show on YouTube: youtube.com/@TheInterviewPodcastFor transcripts and more, visit: nytimes.com/theinterview For more informa ... Show More
49m 59s
Oct 30
The Art of the Pardon: How Trump Turned Clemency Into a Business
In the final stretch of the midterm election campaign, polls have found that voters are latching onto the perceived corruption of the Trump administration.Kenneth P. Vogel, a New York Times investigative journalist, explores one major story line feeding that perception: how those ... Show More
33m 36s
Feb 2021
U.S. closer to first single-dose vaccine after Johnson & Johnson version clears major FDA hurdle; Dem divide on Biden OMB nominee, push for $15 minimum wage; Sheriff: Woods’ survival from crash “nothing short of a miracle”; First interview with Biden’s Veterans Affairs Secretary
Promising signs in pandemic: vaccine progress, cases and hospitalizations down, deaths slow in new estimate; WH: 3-4 million doses of J&J vaccine to go out next week if FDA grants emergency use; Moderna testing vaccine boosters to combat South Africa variant; WH: J&J’s production ... Show More
44m 36s